O
ONWARD Medical NV
XBRU:ONWD
ONWARD Medical NV
XBRU:ONWD
Price:
3.775
EUR
-0.13%
Market Closed
Market Cap:
€211.4m
Income Statement
Earnings Waterfall
ONWARD Medical NV
ONWARD Medical NV
Income Statement
ONWARD Medical NV
ONWARD Medical NV
Currency: EUR
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
6
|
0
|
2
|
0
|
1
|
0
|
2
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+386%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+314%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(29)
|
(34)
|
(32)
|
(36)
|
(36)
|
(36)
|
(35)
|
(37)
|
|
| Selling, General & Administrative |
(13)
|
(15)
|
(15)
|
(18)
|
(17)
|
(17)
|
(18)
|
(22)
|
|
| Research & Development |
(15)
|
(19)
|
(19)
|
(19)
|
(19)
|
(18)
|
(17)
|
(17)
|
|
| Depreciation & Amortization |
(0)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
|
| Other Operating Expenses |
0
|
1
|
2
|
1
|
0
|
(0)
|
2
|
2
|
|
| Operating Income |
(29)
N/A
|
(34)
-19%
|
(32)
+5%
|
(36)
-12%
|
(35)
+1%
|
(36)
-2%
|
(35)
+3%
|
(36)
-3%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
(6)
|
(4)
|
(1)
|
(1)
|
(1)
|
0
|
(1)
|
(2)
|
|
| Total Other Income |
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
(34)
N/A
|
(37)
-9%
|
(34)
+10%
|
(37)
-9%
|
(36)
+1%
|
(36)
+0%
|
(36)
+1%
|
(38)
-6%
|
|
| Net Income | |||||||||
| Tax Provision |
(0)
|
(0)
|
1
|
1
|
(0)
|
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
(34)
|
(38)
|
(33)
|
(36)
|
(36)
|
(35)
|
(36)
|
(38)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(34)
N/A
|
(38)
-9%
|
(33)
+13%
|
(36)
-9%
|
(36)
-1%
|
(35)
+3%
|
(36)
-2%
|
(38)
-7%
|
|
| EPS (Diluted) |
-3.62
N/A
|
-1.24
+66%
|
-1.09
+12%
|
-1.2
-10%
|
-1.2
N/A
|
-1
+17%
|
-0.8
+20%
|
-0.86
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
